Who
John A. Paganelli
Director
Company insider
Files Form 4 as: Interim CEO, COB, Opko Health.
In numbers
- Trades disclosed
- 113
- Buys
- 20
- Sells
- 2
- Bought
- $678K
- Sold
- $97K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 3 Jun 2004
- Last trade
- 18 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 22 Jun 2026 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 20 Mar 2026filed 20 Mar 2026 | OPK Opko HealthBiotechnology | SEC FORM 4 Bought | $11K10,000 at $1.14 | filing |
| 20 Mar 2026filed 20 Mar 2026 | OPK Opko HealthBiotechnology | SEC FORM 4 Bought | $11K10,000 at $1.14 | filing |
| 23 Apr 2025filed 23 Apr 2025 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 5 Jan 2024filed 5 Jan 2024 | OPK Opko HealthBiotechnology | SEC FORM 4 Bought | $22K25,000 at $0.88 | filing |
| 22 Jun 2023filed 23 Jun 2023 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 14 Jul 2022filed 15 Jul 2022 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 24 Jun 2021filed 25 Jun 2021 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 25 Jun 2020filed 26 Jun 2020 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 20 Jun 2019filed 21 Jun 2019 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 9 May 2019filed 10 May 2019 | OPK Opko HealthBiotechnology | SEC FORM 4 Bought | $5,0162,400 at $2.09 | filing |
| 9 May 2019filed 10 May 2019 | OPK Opko HealthBiotechnology | SEC FORM 4 Bought | $16K7,600 at $2.09 | filing |
| 21 Jun 2018filed 22 Jun 2018 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 19 Jun 2017filed 20 Jun 2017 | OPK Opko HealthBiotechnology | SEC FORM 4 Code G | —1,000 at $0.00 | filing |
| 15 Jun 2017filed 16 Jun 2017 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 1 Jun 2017filed 2 Jun 2017 | OPK Opko HealthBiotechnology | SEC FORM 4 Bought | $31K5,000 at $6.17 | filing |
| 6 Mar 2017filed 7 Mar 2017 | OPK Opko HealthBiotechnology | SEC FORM 4 Code M | $69K20,000 at $3.43 | filing |
| 6 Mar 2017filed 7 Mar 2017 | OPK Opko HealthBiotechnology | SEC FORM 4 Code F | $69K9,015 at $7.61 | filing |
| 6 Mar 2017filed 7 Mar 2017 | OPK Opko Healthoption or derivative · Biotechnology | SEC FORM 4 Code M | —20,000 at $0.00 | filing |
News
Greenberg Traurig Advises OPKO Health on $722M+ Agreement to Sell Select BioReference Health Assets to LabcorpOPK · prnewswire.com · 21 Oct 2026Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference HealthOPK · prnewswire.com · 15 Oct 2026
0 headlines in the last 90 days name John A. Paganelli; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.